| 938440-64-3 | Ku-0063794 | KU-0063794 | C25H31N5O4 | 465.54474568367 |
| 1393477-72-9 | Selinexor | KPT-330 | C17H11F6N7O | 443.30596280098 |
| 454453-49-7 | Kobe2602 | 桂利嗪杂质D | C14H9F4N5O4S | 419.310974836349 |
| 436133-68-5 | Kobe0065 | N-(3-氯-4-甲基苯基)-2-[2,6-二硝基-4-(三氟甲基)苯基]-肼硫代甲酰胺 | C15H11ClF3N5O4S | 449.792150735855 |
| 228559-41-9 | KI 8751 | Ki8751 | C24H18F3N3O4 | 469.41263628006 |
| 66592-89-0 | Kevetrin hydrochloride | 4-异硫脲基丁腈盐酸盐 | C5H10ClN3S | 179.6710 |
| 2098902-68-0 | Kdm4D-IN-1 | KDM4D-IN-1 | C11H7N5O | 225.206180810928 |
| 927822-86-4 | N,N'-(Dithiodi-2,1-ethanediyl)bis2,5-dichloro-benzenesulfonamide | N,N'-(亚二硫基双-2,1-乙二基)二[2,5-二氯苯磺酰胺] | C16H16Cl4N2O4S4 | 570.381235122681 |
| 1350622-33-1 | kb-NB77-78 | 二甲基硫化锡 | C18H25NO3Si | 331.481506109238 |
| 1469337-91-4 | N-1-2-(4-Chloro-5-iodo-2-methoxyphenyl)aminoacetyl-4-piperidinylethenesulfonamide | N-[1-[2-[(4-Chloro-5-iodo-2-methoxyphenyl)amino]acetyl]-4-piperidinyl]ethenesulfonamide | C16H21ClIN3O4S | 513.778114080429 |
| 1469337-95-8 | K-Ras(G12C) inhibitor 12 | K-Ras(G12C) inhibitor 12 | C15H17ClIN3O3 | 449.671254873276 |
| 664993-53-7 | JW 55 | N-[4-[[[[四氢-4-(4-甲氧基苯基)-2H-吡喃-4-基]甲基]氨基]羰基]苯基]-2-呋喃甲酰胺 | C25H26N2O5 | 434.484346866608 |
| 1094873-14-9 | Jnj-31020028 | Jnj-31020028 | C34H36FN5O2 | 565.680351257324 |
| 1146963-51-0 | J 147 | 2,2,2-三氟乙酸 1-(2,4-二甲基苯基)-2-[(3-甲氧基苯基)亚甲基]酰肼 | C18H17F3N2O2 | 350.334995031357 |
| 1597403-47-8 | ISRIB (trans-isomer) | trans-ISRIB | C22H24Cl2N2O4 | 451.3430 |
| 1820787-94-7 | Irak4-IN-1 | IRAK4-IN-1 | C19H23N5O | 337.418823480606 |
| 931398-72-0 | IOX2 (Contains ~10% inorganics) | IOX 2 | C19H16N2O5 | 352.340744972229 |
| 1224844-38-5 | Sapanisertib | 3-(2-氨基-5-苯并恶唑基)-1-(1-甲基乙基)-1H-吡唑并[3,4-d]嘧啶-4-胺 | C15H15N7O | 309.325901269913 |
| 914471-09-3 | INCB024360 | 4-氨基-N-(3-氯-4-氟苯基)-N'-羟基-1,2,5-恶二唑-3-甲脒 | C9H7ClFN5O2 | 271.635583162308 |
| 309271-94-1 | Inauhzin | Inauhzin(INZ) 抑制剂 | C25H19N5OS2 | 469.581261873245 |
| 331862-41-0 | IMR-1A | [2-甲氧基-4-[(4-氧代-2-硫代-5-噻唑烷亚基)甲基]苯氧基]乙酸 | C13H11NO5S2 | 325.36 |
| 310456-65-6 | IMR-1 | IMR-1 | C15H15NO5S2 | 353.4133 |
| 36945-98-9 | Icilin | ICILLIN | C16H13N3O4 | 311.292123556137 |
| 186611-52-9 | IC261 | SU-5607 抑制剂 | C18H17NO4 | 311.331885099411 |
| 371242-69-2 | IC-87114 | 2-[(6-氨基-9H-嘌呤-9-基)甲基]-5-甲基-3-(2-甲基苯基)-4(3H)-喹唑啉酮 | C22H19N7O | 397.432563066483 |
| 1640282-31-0 | I-CBP112 | I-CBP 112 | C27H36N2O5 | 468.585147857666 |
| 1637443-98-1 | hVEGF-IN-1 | hVEGF-IN-1 | C34H43N7O2 | 581.750927209854 |
| 173529-46-9 | Hmn-214 | HMN-214 | C22H20N2O5S | 424.469604492188 |
| 5786-54-9 | Hispidol | 毛地尔 | C15H10O4 | 254.2375 |
| 452342-67-5 | GW788388 | GW788388 | C25H23N5O2 | 425.482424974442 |
| 504433-23-2 | GW 441756 | 1,3-二氢-3-[(1-甲基-1H-吲哚-3-基)亚甲基]-2H-吡咯并[3,2-b]吡啶-2-酮 | C17H13N3O | 275.304623365402 |
| 83797-69-7 | 6-OAU | 6-OAU; GTPL5846 | C12H21N3O2 | 239.314042806625 |
| 1346547-00-9 | GSK583 | GSK583 | C20H19FN4O2S | 398.4539 |
| 1619994-68-1 | GSK2801 | GSK2801 | C20H21NO4S | 371.450044393539 |
| 960539-70-2 | Daprodustat | Daprodustat | C19H27N3O6 | 393.434185266495 |
| 1262618-39-2 | GS967 | GS967 | C14H7F6N3O | 347.2153 |
| 839706-07-9 | GNF-7 | N-[3-[1,4-二氢-1-甲基-7-[(6-甲基-3-吡啶基)氨基]-2-氧代嘧啶并[4,5-D]嘧啶-3(2H)-基]-4-甲基苯基]-3-(三氟甲基)苯甲酰胺 | C28H24F3N7O2 | 547.5310754776 |
| 1033769-28-6 | GNF 5837 | GNF 5837 | C28H21F4N5O2 | 535.492259740829 |
| 778277-15-9 | Gnf-5 | N-(2-羟基乙基)-3-[6-[[4-(三氟甲氧基)苯基]氨基]-4-嘧啶基]苯甲酰胺 | C20H17F3N4O3 | 418.369194746017 |
| 200484-11-3 | CHS-828 | N-[6-(4-氯苯氧基)己基]-N'-氰基-N''-4-吡啶基胍 | C19H22ClN5O | 371.863882541656 |
| 1025015-40-0 | 1-(2-{3-(2-phenylethynyl)pyrido2,3-bpyrazin-2-yloxy}ethyl)pyrrolidine | GK921 | C21H20N4O | 344.409704208374 |
| 67469-81-2 | GBR 12935 dihydrochloride | 1-[2-(二苯基甲氧基)乙基]-4-(3-苯基丙基)哌嗪二盐酸盐 | C28H36Cl2N2O | 487.504245758057 |
| 851983-85-2 | Galeterone | Galeterone标准品 | C26H32N2O | 388.545086860657 |
| 1380341-99-0 | GAL-021 | GAL-021 | C11H22N6O | 254.331981182098 |
| 901119-35-5 | Fostamatinib | 福他替尼 | C23H26FN6O9P | 580.459509372711 |
| 1370256-78-2 | SKLB4771 | FLT3-IN-1 | C25H27N7O3S2 | 537.656981706619 |
| 936091-26-8 | Fedratinib | N-(1,1-二甲基乙基)-3-[[5-甲基-2-[[4-[2-(1-吡咯烷基)乙氧基]苯基]氨基]-4-嘧啶基]氨基]苯磺酰胺 | C27H36N6O3S | 524.678144454956 |
| 168682-53-9 | Ezatiostat | EZATIOSTAT游离的 | C27H35N3O6S | 529.648306131363 |
| 934353-76-1 | ENMD-2076 | 6-(4-甲基-1-哌嗪基)-N-(5-甲基-1H-吡唑-3-基)-2-[(1E)-2-苯乙烯基]-4-嘧啶胺 | C21H25N7 | 375.470103025436 |
| 1233948-35-0 | ELR510444 | ELR-510444 | C19H16N2O2S2 | 368.472541809082 |